In last trading session, Pfizer Inc (NYSE:PFE) saw 25.57 million shares changing hands with its beta currently measuring 0.54. Company’s recent per share price level of $24.26 trading at -$0.05 or -0.21% at ring of the bell on the day assigns it a market valuation of $137.93B. That closing price of PFE’s stock is at a discount of -30.01% from its 52-week high price of $31.54 and is indicating a premium of 13.77% from its 52-week low price of $20.92.
For Pfizer Inc (PFE), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.44. Splitting up the data highlights that, out of 16 analysts covering the stock, 1 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 7 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Pfizer Inc (NYSE:PFE) trade information
Upright in the red during last session for losing -0.21%, in the last five days PFE remained trading in the green while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $24.26 price level, adding 0.57% to its value on the day. Pfizer Inc’s shares saw a change of -12.55% in year-to-date performance and have moved 1.08% in past 5-day. Pfizer Inc (NYSE:PFE) showed a performance of 4.03% in past 30-days.
Wall Street analysts have assigned a consensus price target of 24 to the stock, which implies a fall of -1.08% to its current value. Analysts have been projecting 24 as a low price target for the stock while placing it at a high target of 24. It follows that stock’s current price would jump 1.07% in reaching the projected high whereas dropping to the targeted low would mean a gain of 1.07% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -13.25% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -3.52% while estimates for its earnings growth in next 5 years are of -0.25%.
Pfizer Inc (NYSE:PFE)’s Major holders
VANGUARD GROUP INC is the top institutional holder at PFE for having 511.4 million shares of worth $14.31 billion. And as of 2024-06-30, it was holding 9.0258 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 424.38 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.4899 of outstanding shares, having a total worth of $11.87 billion.
